D-dimer Testing Market Size Worth $1.7 Billion By 2027

The global D-dimer testing market size is expected to reach USD 1.7 billion by 2027, expanding at a CAGR of 4.3%, according to a new report by Grand View Research, Inc. Technological advancements in D-dimer testing have resulted in the development of a wide range of products that have allowed healthcare professionals to offer suitable emergency assistance to patients. The concept of automation in D-dimer testing has provided rapid, less labor-intensive, and user-friendly diagnostic strategies, which is expected to drive the market in the near future.

The commercially available assays often have differences in their antibody specificity as D-dimer antibodies also detect Fibrin Degradation Products (FDPs), leading to incorrect results. To address this issue, Advanced ImmunoChemical, Inc. has developed two monoclonal antibodies, which are used to design one-step immunoassay specific for both FDP and D-dimer. Thus, the development of improved immunoassays that equally detect all FDPs is expected to boost the market growth.

Extensive research for the determination of new D-dimer threshold values for a specific population set prevents the usage of Computed Tomography Pulmonary Angiography (CTPA). This is beneficial as the elimination of CTPA leads to low radiation exposure, which, in turn, increases the demand for the test. To demonstrate this, a group of researchers from Japan determined new elevated D-dimer threshold values for the diagnosis of pulmonary embolism in the Japanese population. Such studies are expected to favor market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/d-dimer-market

Further key findings from the report suggest:

  • Reagents and consumables accounted for the largest revenue share in 2019 owing to the wide availability and frequent usage of reagents in the market space
  • Presence of blocking agents that reduce the interferences from heterophilic antibodies to increase the efficiency of immunoassays boost the reagents and consumables segment
  • Shorter turnaround times, ease of use, and generation of gold-standard quality results are among the few factors that lead to a lucrative growth of point-of-care testing
  • Enzyme-linked Immunosorbent Assays (ELISA) held the largest revenue share because microplate ELISA is considered as a reference method due to its high sensitivity for coagulation markers
  • Deep Vein Thrombosis (DVT) dominated the revenue share in 2019 as this test is a reliable method and is used as a routine screening test for DVT
  • The hospitals’ segment accounted for the maximum revenue share in 2019
  • This is attributive to a rise in the rate of pulmonary embolism cases in hospitalized patients, which results in high adoption of the test in hospitals
  • Asia Pacific is expected to witness a lucrative CAGR due to a rise in the funding initiatives that support research studies related to the usage of these assays in various diseases
  • The National Natural Science Foundation of China and the Fundamental Research Funds for the Central Universities are among the few agencies involved in funding research studies in China
  • Key companies operating in the market have undertaken several growth initiatives to expand their product portfolio
  • For instance, in February 2019, HORIBA introduced the Yumizen D-Dimer reagent kit for measurement and reference exclusion testing for DVT and pulmonary embolism.

Apoptosis Assay Market Size Worth $7.5 Billion By 2027

The global apoptosis assay market size is expected to reach USD 7.5 billion by 2027, expanding at a CAGR of 7.6%, according to a new report by Grand View Research, Inc. Extensive research activities on expanding applications of drug-induced apoptosis assays have propelled the inclination of pharmaceutical manufacturers towards incorporating cell cycle products in the drug discovery and designing process.

The introduction of affordable and easy to perform kits that can be accommodated in complex experiments is expected to minimize the overhead costs of apoptosis experiments. Companies are providing highly precise reagents and lot-to-lot reproducibility in sample measurements.

Professionals at pharmaceutical companies are making use of cell-cycle inhibitors and Apoptosis-Inducing Factors (AIF)/ molecules to explore possible drug targets. Also, high demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for apoptosis detection has been observed in recent years. Biotechnology companies are enhancing quantification techniques to enable real-time monitoring of apoptotic cellular dynamics.

The presence of established guidelines and protocols for cell-potency assays has strengthened the development of efficient cell-death detection assays. Whereas, stringent regulations with respect to the approval of cell-potency assays are ensuring successful uptake of market products launched.

The flow cytometry segment dominated the market and accounted for the largest revenue share in 2019. This is attributed to the increasing adoption of the technique among researchers. It helps in finding the difference between intact mitochondria (healthy cells) and permeabilized mitochondria (cells undergoing death). The segment is anticipated to grow fast over the forecast period.

The pharmaceutical and biotechnology segment dominated the market in 2019 and is anticipated to continue its dominance over the forecast period. This is attributed to the rising incidence of cancer and neurodegenerative disorders. In addition, the growing significance of programmed cell death or apoptosis to treat chronic diseases is driving the segment growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/apoptosis-market

Further key findings from the study suggest:

  • The kits segment dominated the market and accounted for a revenue share of around 50.0% owing to increasing investment by key market players
  • Increase in the demand for fluorochrome-labeled inhibitors of caspases has made reagents the fastest growing product segment in the market
  • Application of these inhibitors with other techniques is anticipated to enhance the apoptosis assessment, thereby driving segment growth
  • Owing to the wide adoption and easy availability of products, flow cytometry is estimated to account for a substantial share of approximately 35.0% in 2019
  • The increasing significance of continuous monitoring of programmed cell death across novel drug discoveries and development of advanced therapeutics is set to propel market growth
  • North America has dominated the market in terms of revenue share in 2019, and Asia Pacific is expected to witness the fastest growth in the coming years as a result of the expanding CRO landscape in the region
  • Key companies are competing in terms of a combination of products and services in order to maintain market share.

Active Wheelchair Market Size Worth $2.3 Billion By 2027

The global active wheelchair market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 4.4%, according to a new report by Grand View Research, Inc. Surge in the geriatric and disabled population along with the rising prevalence of chronic diseases in the geriatric population are some of the key factors propelling the market growth.

Aging usually reduces the ability to move and perform physical tasks to maintain independent functioning. The increasing geriatric population is likely to create more demand for active wheelchairs over the forecast period. Moreover, they are more prone to falls, which can cause fatal or non-fatal injuries. The Western Europe region has the highest fall-related incidence and mortality rates in aged people. As per a research article published by Injury Prevention, in 2017, around 11.7 million aged people sought medical attention due to an injury, of which 8.4 million were owing to fall-related injuries. An increasing number of elderly people and rising incidents of falls in the elderly are projected to drive demand for active wheelchairs during the forecast period.

The introduction of technologically advanced active wheelchairs is also expected to drive the market as it provides more comfort to the users. In addition, increasing government initiatives to support the elderly and disabled population is boosting the market. For instance, the U.S. government provides various disability services to its citizens such as insurance for short-term and long-term disability, financial assistance & support services for the disabled, and education & jobs for persons with disabilities. In 2017, the Government of India offered free eldercare assistive devices under RashtriyaVayoshriYojana (RVY) to senior citizens belonging to lower economic strata of the country.

Furthermore, favorable reimbursement policies for the purchase of active wheelchairs, rising incidence of accidents, increasing spending on healthcare infrastructure, and increasing obese population across the globe due to drastic changes in daily lifestyle are also anticipated to propel the growth of the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/active-wheelchair-market

Further key findings from the report suggest:

  • The manual wheelchairs segment was the largest segment in 2019 owing to the low cost of the product and continuous technological advancement to meet the increasing demand in the emerging countries
  • The powered wheelchairs segment is expected to register higher CAGR over the forecast period owing to an increase in product demand especially in developed countries such as the U.S. and Germany
  • Cerebral Palsy was the largest indication segment in 2019 owing to the higher global prevalence of the condition and support offered by the active wheelchairs to the patient with cerebral palsy
  • Europe dominated the market in 2019 with a 33.5% revenue share due to an increase in healthcare expenditure and growing geriatric and disabled population in the region
  • Asia Pacific is expected to register a higher CAGR over the forecast period owing to rising awareness levels and increasing disposable income in the region.

Human Machine Interface Market Worth $6.31 Billion By 2022

The global Human Machine Interface (HMI) market is anticipated to reach USD 6.31 billion by 2022, according to a report by Grand View Research, Inc. Developments in HMI programming software to integrate multi-vendor environment management ability is expected to fuel market growth over the coming years. In addition, advantages offered such as remote operation along with wide usage of HMIs in oil and gas and water treatment units for operating in harsh climates may also boost product demand significantly. This has also instigated companies to develop devices with better wear and tear properties.

Growing trend of protocol conversion for the exchange of data between all connected devices is anticipated to further catalyze HMI market growth. Moreover, technological advancements such as open platform architecture or OPA resulting in improvement of migration process is also likely to spur the demand in coming years.

Factors such as rising need for change in business process to incorporate HMIs along with high upfront capital may have adverse effects on the market development. Furthermore, awareness regarding HMIs among management and lower level staff along with the lack of experienced professionals may also affect the industry growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/human-machine-interface-market

Further key findings from the report suggest:

  • Interface software market accounted for substantial revenue share in 2014. The segment is also anticipated to exhibit high growth with an estimated CAGR exceeding 10% over the next few years. This may be attributed to the increasing adoption of PC- based open source monitoring and controlling system worldwide.
  • Development of new and innovative displays along with emergence of industrial internet of things may contribute towards further growth in the display terminal segment.
  • Oil & gas emerged as the dominant application and accounted for over 20% of the overall revenue in 2014. This may be attributed to increasing demand from the oil & gas sector owing to the benefits offered by HMI regarding the flow of information inside a pipeline without updated monitoring capabilities for overcoming a particular problem.
  • HMI offers several benefits regarding driver safety and security by integrating solutions such as ADAS, ACC and LDW, which are expected to drive demand in the automotive industry.
  • North America HMI market is estimated to hold majority share and accounted for more than 30% of the consumption in 2014. Additionally, Asia Pacific is anticipated to exhibit high growth over the next few years. This may be attributed to the migration of manufacturing processes to developing regions in order to capitalize on labor cost and high availability of raw materials in this region.
  • Companies operating in the industry include GE, Eaton, ABB, Honeywell, Siemens, Omron, Rockwell Automation, Emerson Electric, etc. 

Fuel Cell Vehicles Market Worth $1.75 Billion By 2025

The global fuel cell vehicles market size is expected to reach USD 1.75 billion by 2025, according to a new report by Grand View Research, Inc., registering a 33.7% CAGR during the forecast period. This rapid growth can be attributed to increase in investments by governments over the world for development and adoption of fuel cells.

Fuel cell vehicles ensure emission-free operation, which will effectively reduce the carbon footprint and significantly drive product demand over the next few years. The key factor expected to drive the industry is advancements in fuel cell technology. Ongoing advancements have helped match performance with conventional fuel vehicles, with respect to power output and user experience.

Adoption of fuel cell vehicles worldwide is expected to rise over the forecast period due to increasing awareness about reducing harmful emissions, strict environmental regulations, and growing incentives for use of clean energy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/fuel-cell-vehicle-market

Further key findings from the report suggest:

  • The global fuel cell vehicles market was valued at USD 194.5 million in 2017 and is expected to exhibit a CAGR of 33.7% over the forecast years owing to growing trend of clean energy consumption
  • Several government initiatives and programs to encourage the use of fuel cell vehicles have led to an increase in their adoption, subsequently increasing their demand over the past few years
  • North America accounted for the largest market share in 2017 and is anticipated to exhibit a CAGR of over 36.0% over the forecast period. This can be attributed to massive investments by the United States Department of Energy (DoE) in development of fuel cells and improvement of infrastructure
  • Although the Europe fuel cell vehicles market accounted for just over 3.0% of the overall market revenue in 2017, it is anticipated to be the fastest growing region with CAGR of more than 38.0% over the forecast period
  • Key market players include Toyota Motor Corporation, Honda Motor Company, Ltd., and Hyundai Motor Company. Apart from these, there are several other automobile manufacturers that are in the process of launching their fuel cell vehicles. 

Industrial And Commercial LED Lighting Market Worth $165.91 Billion By 2022

The global industrial and commercial LED lighting market is expected to reach USD 165.91 billion by 2022, according to a new report by Grand View Research, Inc. The high efficiency of LED lights combined with government regulations to ban incandescent lamps is estimated to drive demand over the forecast period.

The increasing shift towards the implementation of cost-effective systems is expected to proliferate demand. Concepts such as smart lighting which offer several benefits including comfort, safety, and security are projected to offer lucrative growth opportunities for the industry. For instance, the prevalence of various smart city schemes across the U.S. and Europe to reduce the consumption of energy and peak power demand is estimated to positively impact sales.

Stringent government regulations and ban on incandescent lamps and set up of minimum efficiency standards by various governments across the globe is further estimated to propel industrial and commercial LED lighting market. For instance, Brazil has banned 60-watt+ and 100-watt incandescent lamps since 2012. Additionally, various legislative actions taken to support these systems and the implementation of various energy-efficient programs are expected to be the critical parameter affecting the industry.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/industrial-commercial-led-lighting-market

Further key findings from the report suggest:

  • The commercial lighting market accounted for over 50% of the overall industry in 2014. Growing demand for LED street lights across various countries including the U.S., China, and Germany is expected to foster growth. Further, increasing the construction of commercial buildings across the globe will impel demand.
  • The industrial segment is expected to witness considerable growth over the next seven years. High pressure to reduce operational and maintenance costs in industries and growing demand for less energy consumption are driving growth across this application.
  • Architectural LED lighting industry accounted for over 30% of the revenue in 2014 and is expected to witness strong growth, owing to the declining average price and continuous improvement in the luminous efficiency of white light.
  • Asia Pacific demand share exceeded 40% in 2014. Increasing construction of office spaces, commercial buildings, and retail stores across countries in Asia Pacific such as Australia, China, and India is estimated to drive the demand for general lighting.
  • Growing energy consumption is estimated to surge demand for efficient lighting technology over the next seven years. LED lights are environment friendly as it does not emit harmful gases resulting in hazardous disorders. It offers varied benefits such as high reliability, brightness, condensed size, and longer life span over incandescent lamps which are projected to contribute to revenue growth.
  • Notable companies comprise GE Lighting, Philips Electronics, Toshiba Corporation, Cree Inc., and Osram Opto. The company’s focus on extending the range of products and services to optimize vertical integration. 

Talent Management Software Market Size Worth $24.03 Billion By 2025

The global talent management software market size is expected to reach USD 24.03 billion by 2025 according to a new report by Grand View Research, Inc. The talent management software industry is anticipated to undergo a series of changes owing to various factors such as decreasing employment rate, changing work environment, the rise of freelancing and contract work, and a globalized workforce.

The most pertinent of the factors is the advent of new software and technologies, such as big data analytics, social media, and the Internet. Mobile platforms are also revolutionizing some important talent management stages, such as recruitment and learning & training, thus driving competition in the market.

Industry leaders have been providing the products in the market for quite some time now but trends such as transparency, customization, and employee engagement are expected to be at the forefront of the new and upcoming offerings to customers. The increasing use of analytics to map the performances and predict the future outcomes has also had a positive effect on the adaptation to the technology in demand.

Solution integration and the availability of middleware from vendors are also an important step forward for the industry standardization. As the industry strides toward larger adoption and rapid developments in terms of capabilities, many new trends such as Massively Open Online Courses (MOOCs) and social media adherence, for either pre-hire assessment or employee feedback management, are gaining traction in the market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/talent-management-software-market

Further key findings from the report suggest:

  • The human resource departments are responsible for decisions concerning talent management systems and are witnessing a shift toward integrated solutions
  • Organizations, they are in search of platforms to integrate the disconnected systems
  • As the industry is moving toward digital management and cloud-based applications, there is a looming threat of data breaches and hacking incidents
  • key players include in the talent management software market are IBM Corp., Oracle Corp., SAP SE, Peoplefluent Inc., CornerStone OnDemand Inc., Haufe Group, Lumesse AS, DelTek Inc., Saba Software Inc., and Halogen Software Inc., among others
  • The industry may also witness a rise in the number of small companies and start-ups that address the niche markets and provide customized solutions while being susceptible to acquisitions and mergers of smaller firms as well as the entry of technology giants to capitalize on the market opportunities

CBD Pet Market Size Worth $399.2 Million By 2027

The global CBD pet market size is expected to reach USD 399.2 million by 2027, expanding at a CAGR of 40.3%, according to a new report by Grand View Research, Inc. increasing health expenditure and growing health concern among the owners of domesticated animals are driving the market. In addition, increasing demand for Cannabidiol (CBD) infused food products is boosting the market growth. Furthermore, increased usage of natural supplements in treating various lifestyle-related disorders in the domesticated animals is fueling the growth.

The cannabidiol infused product is also found useful in cancer-related pain in animals. Rising adoption of domesticated animals and their increased health expenditure are further anticipated to put market growth on the expedited platform in the coming few years. For instance, according to the National Pet Owners Survey carried out by the American Pet Products Association (APPA), around 67.0% of the U.S. households own a domesticated animal that constitutes 85.0 million families in the country as of 2019.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cannabidiol-pet-market

Further key findings from the report suggest:

  • The increased use of cannabidiol infused products and increasing lifestyle-related disorders in domesticated animals is propelling the market growth
  • In terms of revenue, the food-grade segment dominated the market with a revenue share of over 60.0% in 2019, owing to increased product availability and consumption. Moreover, the growing popularity of organic foods among humans as well as domesticated animals is further propelling the demand
  • Cannabidiol oil dominated the therapeutic grade segment as of 2019. The growth can be attributed to its application in various diseases such as joint pain, gut problems, sleep disorder, and anxiety
  • General health/wellness dominated the application segment as of 2019. The growth can be attributed to the growing incidence of arthritis and joint-related disorders in domesticated animals
  • The anxiety/stress application segment is expected to show the fastest growth over the forecast period owing to the increasing application of cannabidiol supplements in anxiety-related disorders in domesticated animals
  • On the basis of end-use, e-commerce held the largest revenue share in 2019 owing to product availability and ease of ordering.

Vaccine Storage & Packaging Market Worth $43.3 Billion By 2027

The global vaccine storage and packaging market size is expected to reach USD 43.3 billion by 2027, expanding at a CAGR of 10.0%, according to a new report by Grand View Research, Inc. Technological advancement in the storage and packaging for medicines, rising government support for research activities and clinical trials, and the growing prevalence of infectious disease are anticipated to drive the market over the forecast period. In addition, increasing government focus on immunization programs, increasing R&D expenditure in biotechnological industries for medical research, and the rising number of pharma retailers are expected to boost the growth of the market. For instance, there are only about 40.0% wards in Nigeria that are equipped with active cold chain equipment. The government of Nigeria is installing at least one functional cold chain equipment in each ward in collaboration with UNICEF, WHO, and CHAI.

Furthermore, most of the biopharmaceutical companies and healthcare institutions are increasingly investing in the development of vaccines. This, in turn, is expected to drive the market over the forecast period. For instance, Innovate UK announced about £66.0 million investment to build and establish a U.K. National Vaccines Manufacturing Innovation Centre in 2018. However, factors such as the availability of refurbished products and stringent regulations are expected to restrain the growth of the market over the forecast period.

Moreover, the COVID-19 outbreak is expected to increase the demand for efficient storage and packaging equipment in the healthcare industry. Most of the global pharmaceutical and biopharmaceutical companies are researching to find a potential vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. The National Institutes of Health (NIH) has partnered with more than 18 biopharmaceutical companies for the development of vaccines against SARS-CoV-2. With the need for global distribution of the approved medicine, high pressure is expected to be built on the cold-chain logistics industry, thus showcasing an opportunity of collaborative efforts among players, leading to industry growth.

In addition, rising awareness about early disease diagnosis and prevention and increasing incidence of infectious diseases has stimulated demand for protective medicines, hence further driving the market. Several efforts undertaken by healthcare organizations such as UNICEF have increased the adoption of protective medicines over the years. UNICEF supply division and Pan American Health Organization (PAHO) revolving fund allow the procurement of medicines at lower prices for various countries. Annually, UNICEF and PAHO procure vaccines for more than 100 countries, which, in turn, is impacting the adoption rate. Thus, capturing market share by means of public contracts is a routine activity of this industry and provides a sustained revenue flow for companies working with government agencies.

An increase in the implementation of the vaccination program by the different governments is one of the major drivers for the market. Increasing vaccination programs have initiated the utilization of public hospitals, clinics, and vaccination centers that has escalated the demand for efficient storage units for the medicines.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/vaccine-storage-packaging-market

Further key findings from the report suggest:

  • By function, the storage segment held the largest market share in 2019 owing to the high cost involved in maintaining the potency of vaccines
  • The storage services segment held the largest market share of over 90.0% in 2019 owing to the increasing demand for vaccine storage services in the industry
  • The packaging segment by the material is sub-segmented into vaccine bags, vials, and ampoules, corrugated boxes, and others. The vaccine bags, vials, and ampoules segment held the largest segment in 2019
  • The packaging segment by packaging level is sub-segmented into the primary, secondary, and tertiary segments. The primary segment held the largest revenue share in 2019 owing to the higher cost of the primary packaging in the industry
  • Europe is anticipated to dominate the market over the forecast period owing to the increasing investments by government and non-government organizations for vaccine development and the high prevalence of infectious diseases within the region.

Sleep Apnea Diagnostic Devices Market Worth $502.9 Million By 2027

The global sleep apnea diagnostic devices market size is anticipated to reach USD 502.9 million by 2027, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Growing incidence of sleep-related disorders and rising prevalence of Obstructive Sleep Apnea (OSA) in health conditions such as Chronic Obstructive Pulmonary Disorder (COPD) is positively impacting the market growth. Furthermore, increasing prevalence of comorbidities associated with the condition such as hypertension, diabetes, obesity, and cardiovascular diseases is anticipated to bolster revenue growth over the forecast period.

Based on product type, the Polysomnography (PSG) segment dominated the market in 2019 with a revenue share of 60.0%. One of the major factors contributing to the increase in product demand includes the development of new devices rendering enhancement in performance. In addition, rising initiatives of insurance coverage for some tests for adults based upon the clinical evaluation of OSA is further propelling segment growth.

North America dominated the market with a revenue share of 45.2% in 2019 owing to the increasing incidence of the population suffering from OSA and other related disorders. Furthermore, technologically advanced healthcare facilities and better reimbursement facilities for such health conditions are boosting the growth in the region. For instance, Medicare and Medicaid provide coverage for certain diagnoses and treatment procedures related to OSA in the U.S. In addition, the rising prevalence of OSA associated chronic health conditions is further fueling the growth of the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sleep-apnea-diagnostic-and-therapeutic-devices-market

Further key findings from the study suggest:

  • The market size is anticipated to witness significant growth over the forecast period owing to the increasing incidence of OSA related disorders
  • The Polysomnography (PSG) segment dominated the market and accounted for a revenue share of 60.0% in 2019, owing to the development of innovative devices with enhanced performance
  • North America dominated the market with a revenue share of 45.2% in 2019, owing to the increasing prevalence of population suffering from OSA related disorders, availability of technologically advanced healthcare facilities, and better reimbursement facilities for such health conditions.